PREPARATION AND CHARACTERIZATION OF POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES FOR TARGETED DELIVERY OF A NOVEL ANTICANCER AGENT, TAXOL

Citation
Ym. Wang et al., PREPARATION AND CHARACTERIZATION OF POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES FOR TARGETED DELIVERY OF A NOVEL ANTICANCER AGENT, TAXOL, Chemical and Pharmaceutical Bulletin, 44(10), 1996, pp. 1935-1940
Citations number
30
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
ISSN journal
00092363
Volume
44
Issue
10
Year of publication
1996
Pages
1935 - 1940
Database
ISI
SICI code
0009-2363(1996)44:10<1935:PACOPA>2.0.ZU;2-A
Abstract
This study describes the preparation and characterization of poly(lact ic-co-glycolic acid) microspheres containing a novel anticancer agent, taxol (namely, Taxol-PLGA-MS), A solvent evaporation technique was ut ilized to prepare Taxol-PLGA-MS, The trapping efficiency of taxol in t he microspheres was greater than 90% and reproducible, The in vitro re lease rate of taxol from the microspheres was very low, and less than 15% of the initial amount of taxol was released in three weeks, irresp ective of the drug loading level, When a chemical additive, isopropyl myristate (IPM), was introduced at the level of 30% (w/w), the release of taxol increased significantly; approximately 70% of the initial am ount of taxol was released at a nearly constant rate for three weeks, Elevation of the loaded IPM level to 50% (w/w) produced a more rapid r elease of the drug, Scanning electron microscopy shelved that Taxol-PL GA-MS were spherical with a smooth surface, More than half (55-65%) of the microspheres had a diameter of 20-45 mu m. Incorporation of IPM h ad no significant influence on the particle size, surface morphology, or degradation behavior of the microspheres. It was strongly suggested that the release of taxol from the microspheres was dominated mainly by the drug diffusion in the matrix, As evaluated from the particle si ze, drug content, and in vitro release property, IPM-containing Taxol- PLGA-MS may be suitable for chemoembolization therapy of cancer diseas es.